Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Biomaterials and regenerative medicine in ophthalmology_Chirila_2010

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
18.34 Mб
Скачать

Engineering the corneal epithelial cell response to materials

199

7.3.2Corneal epithelium/extracelllular matrix structure and repair

The corneal epithelium is composed of three types of cells: basal cells (one layer), wing cells (one to three layers), and squamous cells (three to four layers) – all of which tightly adhere to one another. The basal cells also form strong adhesion complexes with the underlying ECM and, ultimately, with Bowman’s layer.100 Only the basal cells have mitotic capabilities. Like all stratified epithelia in the body, the corneal epithelium is self-renewing; complete cellular turnover occurs every 5–7 days.101 Generally, after the basal cells undergo mitosis, the daughter cells begin to move upward toward terminal differentiation and eventual desquamation from the apical surface.

As part of its protective function, the corneal epithelium also has a strong wound-healing response. After corneal wounding, growth factor and cytokine levels increase in the tear fluid and stromal layers, and a provisional ECM is elaborated. Previous research has shown that epithelial recovery following an external injury is a complex process characterized by three overlapping phases.1 In the first phase, a single layer of epithelial cells at the wound margin becomes motile by forming cellular processes at the wound edge, releasing the hemidesmosomal attachments to the basement membrane and forming a provisional attachment complex called ‘focal contacts’. During this phase, the epithelial cells flatten and migrate as an intact sheet to cover the wound.

Adhesion of the migrating epithelial monolayer to the stroma is thought to be mediated by the glycoprotein FN.102 FN is normally not present beneath corneal epithelial cells but appears after injury and persists until migration is complete. FN contains both cell-specific binding sequences and a binding region for heparin sulfate and type IV collagen (basement membrane components).103 FN provides a temporary, subepithelial matrix on which the epithelial cells can migrate; this occurs in repetitive cycles, during which the cells cleave their attachments, advance, and then form new attachments. Recently, it has become known that a variety of other matrix components – such as LM-5, lumican, fibrin, and perlecan – are found in a temporary or

‘provisional’ matrix in response to wounding.104 A number of LM isoforms have been identified in the wounded cornea, indicating that, not only is LM important in the corneal epithelial cell–substrate adhesion complex, but it may play a role in cell migration during corneal wound healing.

In the second phase of corneal epithelial wound healing, cells distal to the original wound begin to proliferate to repopulate the wound area, and cell stratification and differentiation occur. In the third phase, the epithelium attaches to the basement membrane more firmly, via newly synthesized hemidesmosomes and associated type VII collagen containing anchoring filaments.105 The anchoring filaments pass through the basement membrane

200 Biomaterials and regenerative medicine in ophthalmology

and are contiguous with anchoring fibrils that terminate as anchoring plaques in Bowman’s layer.

Integrins expressed on the corneal epithelial cell surface change during wound healing.106 Among the expressed integrins, α2β1, α3β1, and ανβ1 bind LM, collagen, and FN. Epithelial expression of β1 integrins has been shown to increase as FN in the wound increases and then decreases as wound healing becomes complete. α6β4 integrin is synthesized and redistributed in wound healing and binds LM-5, whereas LM-10 promotes reorganization of filamentous actin (F-actin) in corneal epithelial cells. The proteins LM

(isoforms 1, 5, and 10), k-LM, talin, integrin, and kalinin also play roles in the attachment of the epithelium to the stroma. Although much is known about the factors that make up the adhesion complexes, the precise sequence by which these adhesion complex components are assembled has not yet been fully elucidated. Certain growth factors, such as EGF,107 fibroblast growth factor (FGF)108 and transforming growth factor (TGF)-β1,109 enhance the rate of epithelial wound healing, and human EGF has been specifically shown to induce a dose-dependent increase in epithelial replication in the epithelial stem cells of the corneoscleral limbus.110

Extracellular gradients of growth factors, FN, or LM also may be important. The ECM contains a complex array of fixed charges, and the ionic charge of substrates has been shown to modulate corneal cell integrin expression, cell spreading, and cell motility. Thus, reorganization of cell surface receptors or extracellular molecules to induce a gradient of either receptor or ligand, respectively, is likely an initial event that activates cells asymmetrically, drives subsequent cytoskeletal reorganization, and directs cell migration.

7.3.3Corneal epithelial cell repair and growth ligands

Elucidation of signaling events and the underlying biological factors that produce them is key to understanding the fundamental elements required to produce an ECM-like environment. Identification of these important moieties for corneal epithelial cells has been substantial to date. LM and FN are multifunctional ECM proteins that play a central role in cell adhesion and migration. Expression of integrin receptors for both of these proteins has been shown to occur within hours of the ligands being detected in the matrix.37 LM is a major component of the intact basal lamina and has been shown to enhance epithelial cell adhesion and spreading on surfaces. Twelve isoforms of LM have been identified; however, only three isoforms – LM-1, LM-5, and LM-10 – have been consistently found within the basement membrane of the cornea.111, 112 In unwounded corneas, expression of lumican is limited to stromal keratocytes. The expressed lumican molecules are glycanated with keratin sulfate. In healing corneal wounds, a non-glycanated form of

Engineering the corneal epithelial cell response to materials

201

lumican is produced and has been shown to significantly enhance epithelial cell migration and proliferation.113

FN, seen on the surface of healing epithelial wounds, is an insoluble glycoprotein dimer (unlike the soluble disulfide linked dimer) found in plasma. The primary transcript of FN is alternatively spliced and, therefore, different isoforms, such as EDA-, EDB-, CS1-, and a further isoform, OncFn, are expressed by alternative glycosylation.114 Exogenous FN has been shown to promote the healing of corneal epithelial wounds experimentally

in vivo and in vitro, and the healing of persistent corneal epithelial defects in humans.115 FN is widely expressed in the cornea and EDA-FN emerges

during wound healing.116 In addition, studies have concluded that the cell adhesion properties of FN can be generated using only peptide fragments of the molecule.103 FN peptide sequences, RGD (the central cell binding domain) and PHSRN (from the ninth type II repeating unit), when co- localized, have been found to enhance the cell-adhesive activity of RGD.68 Fibronection adhesion peptide (FAP), the carboxy-terminal heparin binding and cell adhesion-promoting domain, from within the FN molecule, has been shown to promote attachment and spreading of several cultured cell lines including corneal epithelial cells.117, 118 YIGSR is a peptide sequence from the LM A chain that has also demonstrated the ability to promote cell attachment and spreading in corneal epithelial cells.119

7.3.4Engineering surfaces for corneal epithelial growth and health

A number of different surface modification techniques have been investigated in the attempt to foster productive biological interactions between the modified elastomer/hydrogel surface and the corneal epithelial cell membrane. Franco et al.120 evaluated the interactive effects of different surface functionalities with corneal epithelial cells using self-assembled monolayers of alkanethiols and

alkylsiloxanes. In addition, several investigators have used plasma modification of various surfaces including silicone rubber121–123 and polyvinyl alcohol124

to improve the corneal epithelial cell response with limited success.

Adsorption and direct covalent attachment of ECM proteins such as FN and LM, as well as collagens types I and IV, to various surfaces have also been investigated. Hydrogels pre-adsorbed with types I and IV collagen showed a more rapid rate of cell growth than those coated with either FN or LM.125, 126 Adsorption of FN to a collagen-modified surface resulted in further acceleration of corneal cell attachment.127, 128 Collagen-modified corneal inlays also maintained a healthy, differentiated, and stratified epithelium with focal attachments for over 6 weeks in feline corneas.129 More recent studies with polyvinyl alcohol substrates modified with collagen and amniotic membrane also resulted in stratified corneal epithelium over finite time periods.130, 131

202 Biomaterials and regenerative medicine in ophthalmology

However, collagen-modified surfaces have been shown to be susceptible to collagenase activity over time. The ability of these modified surfaces to exist over the lifetime of the implant is not clear.

Cell adhesion peptides – including RGD, YIGSR, and a novel collagen peptoid Gly-Pro-nLeu – directly attached to surfaces have also been studied,

but these peptide/peptoid modifications have produced only modest increases in the rate of epithelialization in vitro.38, 132–135 However, direct attachment of

YIGSR throughout a collagen matrix increased not only epithelialization rates and produced some stratification of the epithelium but also neurite in-growth after 6 weeks of implantation in porcine corneas.119 In general, although a few replacement materials with either coating and/or direct attachment of biological factors (both proteins and peptides) to their surfaces have had some short-term success in maintaining a somewhat normal epithelial layer,

long-term analysis (up to 8 years) has shown that the density of the epithelial layer is not maintained.135–139

Investigations into the use of spacers or tethers to increase the long-term corneal epithelial cell health over hydrogel materials have been reported. These include studies to develop and test a wet chemistry method to covalently bond PEG-tethered ECM proteins and/or peptides on to the surface of a hydrogel.140, 141 The resultant hydrogels were biologically active and possessed physical characteristics similar to the natural cornea. Analysis of the corneal epithelial cell response to six different tether-modified hydrogels showed that, while little to no cell growth occurred on plain (unmodified) hydrogels, and only a maximum confluence of 20% occurred on protein/ peptide-coated hydrogels, three types of tether-modified hydrogels (LM, an FN adhesion peptide sequence (FAP), and FN/LM (1:1)) all achieved 100% confluence at the end of the same culture period.142 However, the rate of cell confluence was considerably different for the three different tether-modified hydrogels. LM-only-tethered surfaces initially had significantly less cell growth than the surfaces with FAP-only or FN/LM. However, during the last third of the culture period, the rate of epithelial cell confluence over the LM-only modified surfaces surpassed that of the FN/LM surface. This result indicates that FN or a ligand within the FN molecule is a key component for early epithelial cell adhesion and replication in cell culture. The relative strength of the cellular attachment to the tether-modified hydrogel surfaces was determined with jet impingement. Epithelial cells grown on LMand

FAP-tethered hydrogel surfaces attached with significantly higher adhesion strengths than any other type of tether-modified hydrogel.143 There are several possible explanations for the significantly lower adhesion strength to the FN-modified surfaces: (1) the modified surfaces presented too little FN to provide the ligand surface concentration necessary for the formation of stable epithelial cell receptor–ligand bonds; (b) the percentage of FN-bound molecules bound to the surface with the appropriate receptor binding sites

Engineering the corneal epithelial cell response to materials

203

exposed to the epithelial cells was inadequate for strong cell adhesion; and

(c) the tethering technique presented competitive ligand sites on the FN molecule that have a down-regulating effect on epithelial cell adhesion. Further studies are needed to clarify these issues. Addition of PEG-tethered EGF to allylamine-activated polydimethylsiloxane (PDMS) by other investigators also showed increased epithelial cell coverage rates as compared with unmodified controls in both serum-free and EGF-free medium studies.144 Overall these studies support the hypothesis that tethering proteins and peptides increases their ability to interact with cell membrane receptors and, therefore, only very small amounts (<0.1 μg/cm2) of proteins and/or peptides are necessary to elicit a cellular response.

In addition to which biological factors are added to the surface and by what method, the spatial density of the addition is important. The natural substrate has a variety of biological factors spatially distributed for cell signaling. Therefore, the optimal biomimetic surface for engineering the cell response would have a nanopatterned distribution of biological factors over its surface. There are three main methods for providing reactive groups on the surface for addition of the tethered moieties including (a) monomer pendant groups within the base polymer;140 (b) addition of reactive groups (acetaldehyde or allylamine) or reactive polymers through plasma addition;144 and addition of reactive groups through photopatterning.145 The ability to specifically populate a surface with combinations of signaling moieties can require extensive blocking chemistry unless specific patterning techniques are used. Spatially controlled patterning of the surface, by masking during the plasma polymerization, for increased corneal epithelial outgrowth recently showed preferential binding of collagen I and cell growth on those areas.146 However, the areas of photopatterning in this study were very large (13 mm) in relation to cell size. Continued research into developing nano-scale patterning methods for the spatial addition of specific cell-activating moieties will be important in furthering developments in this area.

Engineering of corneal epithelial cell attachment and growth should focus not only on the structure of the normal epithelial ECM but also on how the natural cornea heals a de-epithelialized stroma. Knowledge of the important cell signaling events and the biological factors that produce them provides the researcher with the fundamental elements needed to produce an ECM-like environment. Engineering a surface to mimic the natural corneal epithelial ECM and basement membrane sufficiently involves populating the surface with enough cellular signals (proteins/peptides) to initiate cell attachment, migration, differentiation, and stratification and then maintain the stratified epithelium over time. As more detailed information on the specific isoforms of proteins and functions of peptide sequences becomes available, more advanced surfaces can be developed. In addition to further refinement of the type of tethered moieties, optimization of their exact

204 Biomaterials and regenerative medicine in ophthalmology

quantity and spatial distribution is needed to develop a truly biomimetic surface.

7.4References

1Zieske JD: Extracellular matrix and wound healing. Curr Opinion Ophthalmol 12(4), 237–241, 2001.

2Aumailley M, Gayraud B: Structure and biological activity of the extracellular matrix. J Mol Med 76, 253–65, 1998.

3Bosman FT, Stamenkovic I: Functional structure and composition of the extracellular matrix. Pathology 200, 423–428, 2003.

4Horbett TA: The role of adsorbed proteins in animal cell adhesion. Colloids Surf B Biointerfaces 2, 225–240, 1994.

5Hattori S, Andrade JD, Hibbs JB Jr, Gregonis DE, King RN: Fibroblast cell proliferation on charged hydroxyethyl methacrylate copolymers. J Colloid Interface Sci 104, 72–78, 1985.

6Wu XY, Cornell-Bell A, Davies TA, Simons ER, Trinkaus-Randall V: Expression of integrin and organization of F-actin in epithelial cells depends on the underlying surface. Invest Ophthalmol Vis Sci 35, 878–890, 1994.

7Lymann DJ, Muir WM, Lee IT: The effect of chemical structure and surface properties of polymers on the coagulation of blood. I. Surface free energy effects.

Trans Am Soc Artific Intern Organs 11, 301–306, 1965.

8Andrade JD, Hattori S, King RN: Surface characterization of poly (hydroxyethyl methacrylate) and related polymers I. Contact angle method in water. J Polym Sci: Polym Symp 66, 313–319, 1979.

9Absolom DR, Zing W, van Oss CJ, Neumann AW: Protein and platelet interaction with polymer surfaces. Biomater Med Devices Artif Organs 12, 235–266, 1984/85.

 

10

Ruardy TG, Schakenraad JM, van der Mei HC, Busscher HJ: Adhesion and spreading

 

 

of human skin fibroblasts on physicochemically characterized gradient surfaces. J

 

 

Biomed Mater Res 29, 1415–1423, 1995.

 

11

Bohnert JL, Horbett TA, Ratner DB, Royce FH: Adsorption of proteins from artificial

 

 

tear solutions to contact lens materials. Invest Ophthalmol Vis Sci 29, 362–373,

 

1988.

12

Yasuda H, Yamanashi BS, Devito DP: The rate of adhesion of melanoma cells

 

 

 

onto nonionic polymer surfaces. J Biomed Mater Res 12, 701–706, 1978.

 

13

van Wachem PB, Hogt AH, Beugeling T, Freijen J, Bantjes A, Detmer JP, van Aken

 

 

WG: Adhesion of cultured human endothelial cells onto methacrylate polymers

 

 

with varying surface wettability and charge. Biomaterials 8, 323–328, 1987.

 

14

Kothari S, Hatton PV, Danglas CWI: Protein adsorption to titanic surface. J Mater

 

 

Sci 6, 695–698, 1995.

 

15

Altankov G, Groth T: Reorganization of substratum on hydrophilic and hydrophobic

 

 

materials is related to biocompatibility. J Mater Sci 5, 732–737, 1994.

 

16

Groth T, Altankov G: Studies on cell-biomaterial interaction: role of tyrosine

 

 

phosphorylation during fibroblast spreading on surfaces varying in wettability.

 

 

Biomaterials 17, 1227–1234, 1996.

 

17

Lampin M, Werocquier-Clérout R, Legris C, Degrange M, Sigot-Luizard MF:

 

 

Correlation between substratum roughness and wettability, cell adhesion, and cell

 

 

migration. J Biomed Mater Res 36, 99–108, 1997.

 

Engineering the corneal epithelial cell response to materials

205

18

Goodman SL, Sims PA, Albrecht RM: Three-dimensional extracellular matrix

 

textured biomaterials. Biomaterials 17, 2087–2095, 1996.

 

19

Abrams GA, Goodman SL, Nealey PF, Franco M, Murphy CJ. Nanoscale topography

 

of the basement membrane underlying the corneal epithelium of the rhesus macaque.

 

Cell Tissue Res 299, 39–46.

 

20

Fitton JH, Dalton BA, Beumer G, Johnson G, Griesser HJ, Steele JG: Surface

 

topography can interfere with epithelial tissue migration. J Biomed Mater Res 42,

 

245–257, 1998.

 

21

Steele JG, Johnson G, McLean KM, Beumer GJ, Griesser HJ: Effect of porosity

 

and surface hydrophilicity on migration of epithelial tissue over synthetic polymer.

 

J Biomed Mater Res 50, 475–482, 2000.

 

22

Yim EKF, Reano RM, Pang SW, Yee AF, Chen CS, Leong KW: Nanopattern-

 

induced changes in morphology and motility of smooth muscle cells. Biomaterials

 

26, 5405–5413, 2005.

 

23

MacRitchie R: The adsorption of proteins at the solid/liquid interface. J Colloid

 

Interface Sci 38, 484–488, 1972.

 

24

Hoffman AS: Blood–biomaterial interactions: an overview. In: Biomaterials:

 

Interfacial Phenomena and Applications. Cooper SL, Peppas NA (eds). Advances

 

in Chemistry Series 199, Oxford University Press, New York, 1982, p. 3.

 

25

Castillo EJ, Koenig JL, Anderson JM, Lo J: Protein adsorption on hydrogels. II.

 

Reversible and irreversible interactions between lysozyme and soft contact lens

 

surfaces. Biomaterials 6, 338–344, 1985.

 

26

Castillo EJ, Koenig JL, Anderson JM, Lo J: Characterization of protein adsorption

 

on soft contact lenses. I. Conformational changes of adsorbed human serum albumin.

 

Biomaterials 5, 319–325, 1984.

 

27

Pitt WG, Spiegelberg SH, Cooper SL: Adsorption of fibronectin to polyurethane

 

surfaces: Fourier transformed infrared spectroscopic studies. In: Proteins and

 

Interfaces: Physicochemical and Biochemical Studies. Brash JL, Horbett TA

 

(*eds). ACS Symposium Series 343, Oxford University Press, New York, 1977,

 

pp. 324–338.

 

28

Grinnell F, Feld MK: Adsorption characteristics of plasma fibronectin in relationship

 

to biological activity. J Biomed Mater Res 15, 363–381, 1981.

 

29

Steele JG, McFarland C, Dalton BA, Johnson G, Evans MD, Howlett CR, Underwood

PA: Attachment of human bone cells to tissue culture polystyrene: the effect of

 

surface chemistry upon initial cell attachment. J Biomater Sci Polymer Edn 5,

 

245–257, 1993.

 

30

Howlett CR, Evans MDM, Walsh WR, Johnson G, Steele JG: Mechanism of initial

 

attachment of cells derived from human bone to commonly used prosthetic materials

 

during cell culture. Biomaterials 15, 213–222, 1994.

 

31

Juliano DJ, Saavedra SS, Truskey GA: Effect of the conformation and orientation

 

of adsorbed fibronectin on endothelial cell spreading and the strength of adhesion.

 

J Biomed Mater Res 27, 1103–1113, 1993.

 

32

Groth TH, Zlatanov I, Altankov G: Adhesion of human peripheral lymphocytes on

 

biomaterials preadsorbed with fibronectin and vitronectin. J Biomater Sci Polymer

 

Edn 6, 729–739, 1994.

 

33

Truskey GA, Proulx TL: Relationship between 3T3 cell spreading and the strength

 

of adhesion on glass and silane surfaces. Biomaterials 14, 243–254, 1993.

 

34

Andrade JD, Hlady V: Protein adsorption and materials biocompatibility: A tutorial

 

review and suggested hypothesis. Prog Surface Sci 79, 1–64, 1986.

 

206

Biomaterials and regenerative medicine in ophthalmology

35

Norde W, Lyklema J: Why proteins prefer interfaces. J Biomater Sci Polymer Edn

 

2, 183–202, 1991.

36

Kirkham SM, Dangel ME: The keratoprosthesis: improved biocompatibility through

 

design and surface modification. Ophthalmic Surg 22, 455–461, 1991.

37

Grushkin-Lerner LS, Kewalramani R, Trinkaus-Randall V: Expression of integrin

 

receptors on plasma membranes of primary corneal epithelial cells is matrix specific.

 

Exp Eye Res 64, 323–334, 1997.

38

Trinkaus-Randall V, Vural M, Capecchi J, Franzblau C, Leibowitz HM: Modification

 

of polymers for synthesis by corneal epithelial cells. Invest Ophthalmol Vis Sci

 

32(suppl), 1072, 1991.

39

Steele JG, Johnson G, Griesser HJ, Underwood PA: Mechanism of initial attachment

 

of corneal epithelial cells to polymeric surfaces. Biomaterials 18, 1541–1551,

 

1997.

40

Paulsson M, Kober M, Freij-Larsson C, Stollenwerk M, Wesslen B and Ljungh Å:

 

Adhesion of staphylococci to chemically modified and native polymers, and the

 

influence of preadsorbed fibronectin, vitronectin and fibrinogen. Biomaterials 14,

 

845–853, 1993.

41

Pettit DK, Horbett TA, Hoffman AS: Influence of the substrate binding characteristics

 

of fibronectin on corneal epithelial cell outgrowth. J Biomed Mater Res 26, 1259–1275,

 

1992.

42

Pettit DK, Hoffman AS, Horbett TA: Correlation between corneal epithelial cell

 

outgrowth and monoclonal antibody binding to the cell binding domain of adsorbed

 

fibronectin. J Biomed Mater Res 28, 685–691, 1994.

43

Altankov G, Grinnell F, Groth TH: Studies on the biocompatibility of materials:

 

fibroblast reorganization of substratum-bound fibronectin on surfaces varying in

 

wettability. J Biomed Mater Res 33, 494–499, 1999.

44

Grinnell F, Feld M: Fibronectin adsorption on hydrophilic and hydrophobic surfaces

 

detected by antibody binding and analyzed during cell adhesion in serum containing

 

medium. J Biol Chem 257, 4888–4893, 1982.

45

van Wachem PB, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG:

 

Interaction of cultured human endothelial cells with polymeric surfaces of different

 

wettabilities. Biomaterials 6, 403–408, 1985.

46

van Koten TG, Schakenraad A, van der Mei HC, Busscher HJ: Influence of substratum

wettability on the strength of adhesion of human fibroblasts. Biomaterials 12, 897,

 

1992.

47

Chen W, Hasegawa C, Hasegawa T, Wenstock C, Yamada K: Development of cell

 

surface linkage complexes in cultured fibroblasts. J Cell Biol 100(4), 1103–1114,

 

1985.

48

Massia SP, Hubbell JA: Covalent surface immobilization of Arg-Gly-Asp- and Tyr-

 

Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates.

 

Analyt Biochem 187, 292–301, 1990.

49

Murphy WL, Mercurius KO, Koide S, Mrksich M: Substrates for cell adhesion

 

prepared via site-directed immobilization of a protein domain. Langmuir 20,

 

1026–1030, 2004.

50

Massia SP, Hubbell JA: An RGD spacing of 440 nm is sufficient for integrin

 

αvβ3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber

 

formation. J Cell Biol 12, 1089–1100, 1991.

51

Tashiro K-I, Sephel GC, Greatorex D, Sasaki M, Shirashi N, Martin GR, Kleinman

 

HK, Yamada Y: The RGD containing site of the mouse laminin A chain is active

 

Engineering the corneal epithelial cell response to materials

207

 

for cell attachment, spreading, migration and neurite outgrowth. J Cell Physiol 146,

 

451–459, 1991.

 

52

Massia SP, Rao SS, Hubbell JA: Covalently immobilized laminin peptide Tyr-

 

Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and co-localization of the 67-

 

kilodalton laminin receptor with α-actinin and vinculin. J Biol Chem 268, 8053–8059,

 

1993.

 

53

Lin H-B, Sun W, Mosher DF, Garcia-Echeverría C, Schaufelberger K, Lelkes

 

PI, Cooper SL: Synthesis, surface, and cell-adhesion properties of polyurethanes

 

containing covalently grafted RGD-peptides. J Biomed Mater Res 28, 329–342,

 

1994.

 

54

Olbrich KC, Andersen TT, Blumenstock FA, Bizios R: Surfaces modified with

 

covalently-immobilized adhesive peptides affect fibroblast population motility.

 

Biomaterials 17, 759–764, 1996.

 

55

Glass JR, Dickerson KT, Stecker K, Polarek JW: Characterization of a hyaluronic

 

acid–Arg–Gly–Asp peptide cell attachment matrix. Biomaterials 17, 1101–1108,

 

1996.

 

56

Hern DL, Hubbell JA: Incorporation of adhesion peptides into nonadhesive hydrogels

 

useful for tissue resurfacing. J Biomed Mater Res 39, 266–276, 1998.

 

57

Watanabe K, Berman M: Mechanisms of persistent epithelial defect formation:

 

peptide from the cell-domain (GRGDS) inhibits corneal epithelial cell migration.

 

Invest Ophthalmol Vis Sci 29(suppl), 192, 1988.

 

58

Kugo K, Okuno M, Masusa K, Nishino J, Masufa H, Iwatsuki M: Fibroblast

 

attachment to Arg–Gly–Asp peptide-immobilized poly(gamma-methyl L-glutamate).

 

J Biomater Sci Polymer Edn 5, 325–327, 1994.

 

59

Griffith-Cima L: Polymer substrates for controlled biological interactions. J Cell

 

Biochem 56, 155–161, 1994.

 

60

Jeon SI, Lee JH, Andrade JD, DeGennes PG: Protein–surface interactions in the

 

presence of polyethylene oxide. I. Simplified theory. J Colloid Interface Sci 142,

 

149–158, 1991.

 

61

Bergstrom K, Holmberg K, Safranj A, Hoffman AS, Edgell MJ, Kozlowski A,

 

Hovanas BA, Harris JM: Reduction of fibrinogen adsorption on PEG-coated

 

polystyrene surfaces. J Biomed Mater Res 26, 779–790, 1992.

 

62

D’Urso EM, Jean-Francois J, Fortier G: Bioapplication of poly(ethylene glycol)-

albumin hydrogels: Matrix for enzyme immobilization. In: Hydrogels and

 

Biodegradable Polymers for Bioapplications. Ottenbrite RM, Huang SJ, Park K

 

(eds). American Chemical Society, Washington, 1996, pp. 25–41.

 

63

Kuhl PR, Griffith-Cima LG: Tethered epidermal growth factor as a paradigm for

 

growth factor-induced stimulation from the solid phase. Nat Med 2, 1022–1027,

 

1996.

 

64

Griffith-Cima L: Tissue engineered scaffolds for liver regeneration. Presented at

 

Molecular Engineering of Polymers Workshop: Directing Biological Response.

 

American Chemical Society, Washington November, 1996.

 

65

Nomizu M, Kim WH, Yamamura K, Utani A, Song SY, Ottaka A, Roller PP:

 

Identification of cell binding sites in the laminin alpha 1 chain carboxyl-terminal

 

globular domain by systemic screening of synthetic peptides. J Biol Chem 270,

 

20583–20590, 1995.

 

66

Aota S, Nomizu M, Yamada K: The short amino acid sequence Pro–His–Ser–

 

Arg–Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 269,

 

24756–24761, 1994.

 

 

208

Biomaterials and regenerative medicine in ophthalmology

 

67

Cameron JD, Mooradian DL, Furcht LT: Rabbit corneal epithelial cell adhesion to

 

 

proteolytic fragments and synthetic peptides of fibronectin. Invest Ophthalmol Vis

 

 

Sci 32(suppl), 1072, 1991.

 

68

Benoit DS, Anseth KS: The effect on osteoblast function of colocalized RGD and

 

 

PHSRN epitopes on PEG surfaces. Biomaterials 26, 5209–5220, 2005.

 

69

Gasset AR, Kaufman H: Epikeratoprosthesis. Replacement of superficial cornea by

 

 

methyl methacrylate. Am J Ophthalmol 66, 641–645, 1968.

 

70

Binder PS, Deg JK, Zavala EY, Grossman RG: Hydrogel keratophakia in non-human

 

 

primates. Curr Eye Res 1, 535, 1981/82.

 

71

Samples JR, Binder PS, Zavala EY, Baumgartner SD, Deg JK: Morphology of

 

 

hydrogel implants used for refractive keratoplasty. Invest Ophthalmol Vis Sci 25,

 

 

843–850, 1984.

 

72

Werblin TP, Fryczkowski AW, Peiffer RL: Myopic correction using alloplastic

 

 

implants in non-human primates – a preliminary report. Ann Ophthalmol 16(12),

 

 

1127–1130, 1984.

 

73

Quengsy Pellier de: Precis ou cours d’operations sur la chirurgie de yeux. Didot,

 

 

Paris, 1789.

 

74

Nussbaum A: Corn Artef. Munich, 1853.

 

75

Cuperus PL, Jongebloed WL, van Andel P, Worst JGF: Glass–metal keratoprosthesis:

 

 

light and electron microscopical evaluation of experimental surgery on rabbit eyes.

 

 

Doc Ophthalmol 71, 29–47, 1989.

 

76

Linnola RJ, Happonen RP, Andersson OH, Vedel E, Yli-Urpo AU, Krause U,

 

 

Laatikainen L: Titanium and bioactive glass-ceramic coated titanium as materials

 

 

for keratoprosthesis. Exp Eye Res 63, 471–478, 1996.

 

77

Ricci R, Pecorella I, Ciardi A, Della Rocca C, Di Tondo U, Marchi V: Strampelli’s

 

 

osteo-odonto-keratoprosthesis. Clinical and histological long-term features of three

 

 

prostheses. Br J Ophthalmol 76, 232–234, 1992.

 

78

Sommer G: Neue Versuche sur Allopastic der Kornea. Klin Monatsbl Augenheilkd

 

 

122, 545–554, 1953.

 

79

Stone W Jr, Herbert E: Experimental study of plastic material as replacement for

 

 

the cornea. Am J Ophthalmol 36, 168–173, 1953.

 

80

Cardona H: Keratoprosthesis. Acrylic optical cylinder with supporting intralamellar

 

 

plate. Am J Ophthalmol 54, 284–294, 1962.

81

Girard LJ, Hawkins RS, Nieves R, Borodofsky T, Grant C: Keratoprosthesis:

 

 

A 12-year follow-up. Trans Am Acad Ophthalmol Otolaryngol 83, 525–267,

 

 

1977.

 

82

Cardona H: The Cardona keratoprosthesis: 40 years experience. Refract Corneal

 

 

Surg 7, 468–471, 1991.

 

83

Jacob-LaBarre JT, Caldwell DR: Development of a practical artificial cornea for

 

 

end stage corneal diseases. Transactions of the Thirteenth Annual Meeting for the

 

 

Society for Biomaterials, New York City. Volume X, 1987, p. 57.

 

84

Jacob-LaBarre JT, Caldwell DR: Development of a soft artificial cornea for end

 

 

stage corneal diseases. Proceedings of the American Chemical Society Division of

 

 

Polymeric Materials: Science and Engineering, Los Angeles, California, Volume

 

 

59, 1988, pp. 95–99.

 

85

Trinkaus-Randall V, Capecchi J, Newton A, Vadasz A, Leibowitz H, Franzblau C:

 

 

Development of a biopolymeric keratoprosthetic material. Invest Ophthalmol Vis

 

 

Sci 29(3), 393–400, 1988.

 

86

Dupont D, Gravagna P, Albinet P, Tayot JL, Romanet JP, Mouillon M, Eloy R: